
Mirion Technologies, Inc.
MIRNYSEIndustrialsIndustrial - Machinery
Previous close
$14.82
−$0.41 · -2.69%
MIR company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
43
Fair Value
Momentum
27
Weakening
Sentiment
69
Bullish
Risk resilience
41
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteMirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
- Industry
- Industrial - Machinery
- Sector
- Industrials
- Headquarters
- US
- CEO
- Thomas D. Logan
- Listed since
- Aug 20, 2020
- Employees
- 3,281
Market position
Day range
Current $14.82
52-week range
Current $14.82
- Open
- $15.40
- Previous close
- $15.23
- Volume
- 4.06M
- 1× average
- Average volume
- 4.07M
- Average daily volume
- Market cap
- 3.61B USD
- Beta
- 1.06
- Market reference 1
- 50-day average
- $16.444
- -9.88% below average
- 200-day average
- $20.58
- -27.99% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 6.21B USD
- P/E (TTM)
- 149.7×
- P/B (TTM)
- 1.99×
- P/S (TTM)
- 3.52×
- EV / EBITDA
- 29.15×
- Earnings yield
- 0.53%
- Free cash flow yield
- 1.98%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 48.00%
- Operating margin
- 5.32%
- Net margin
- 2.39%
- Return on equity
- 1.54%
- Return on assets
- 0.80%
- Return on invested capital
- 1.43%
Financial health
- Debt / equity
- 0.68×
- Current ratio
- 2.83×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 925.4M USD | 860.8M USD | 800.9M USD | 717.8M USD | 668.3M USD |
| Cost of goods sold | 486.8M USD | 459M USD | 444.4M USD | 400.6M USD | 384.1M USD |
| Gross profit | 438.6M USD | 401.8M USD | 356.5M USD | 317.2M USD | 284.2M USD |
| Research and development | 38.9M USD | 35M USD | 31.7M USD | 30.3M USD | 36.2M USD |
| Selling, general, and administrative | 348.2M USD | 338.2M USD | 338.6M USD | 357.1M USD | 267.6M USD |
| Operating expenses | 387.1M USD | 377M USD | 378.4M USD | 615M USD | 352.9M USD |
| Interest income | 12.1M USD | 6.6M USD | 4.8M USD | 600K USD | 145.8M USD |
| Interest expense | 42.2M USD | 57.9M USD | 61.9M USD | 42.5M USD | 59M USD |
| Depreciation and amortization | 138M USD | 150.4M USD | 162.8M USD | 174.5M USD | 112.2M USD |
| Operating income | 51.5M USD | 24.8M USD | −21.9M USD | −297.8M USD | −68.7M USD |
| Net income | 28.8M USD | −36.1M USD | −96.9M USD | −276.9M USD | −222.5M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 55%
- 6 beats, 2 misses, 3 met estimates
- Average EPS surprise
- +5.02%
- 11 comparable reports
- Latest EPS result
- 0.12
- Estimate 0.1 · Beat by 16.05%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
9 ratingsRecent analyst actions
MIR news
MIR peers
ETFs holding MIR
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR234.15M0.21%111.19B USD0.06%$147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI110.86M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM94.25M0.12%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB79.99M0.04%183.4B USD0.03%$304.76+0.64%
Vanguard Information Technology ETFVGT77.49M0.05%160.2B USD0.09%$118.42+0.05%
Vanguard Morningstar Small-Cap Value ETFVBR50.84M0.07%68.3B USD0.05%$249.18+0.68%
Vanguard Extended Market ETFVXF42.2M0.04%93.7B USD0.05%$245.53+0.82%
iShares S&P Small-Cap 600 Growth ETFIJT35.63M0.42%8.22B USD0.18%$173.9+0.61%
iShares Core S&P Small-Cap ETFIJR- Market value
- 234.15M
- Weight
- 0.21%
- AUM
- 111.19B USD
- Expense ratio
- 0.06%
- Price / 1D
- $147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 110.86M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 94.25M
- Weight
- 0.12%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 79.99M
- Weight
- 0.04%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Information Technology ETFVGT- Market value
- 77.49M
- Weight
- 0.05%
- AUM
- 160.2B USD
- Expense ratio
- 0.09%
- Price / 1D
- $118.42+0.05%
Vanguard Morningstar Small-Cap Value ETFVBR- Market value
- 50.84M
- Weight
- 0.07%
- AUM
- 68.3B USD
- Expense ratio
- 0.05%
- Price / 1D
- $249.18+0.68%
Vanguard Extended Market ETFVXF- Market value
- 42.2M
- Weight
- 0.04%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares S&P Small-Cap 600 Growth ETFIJT- Market value
- 35.63M
- Weight
- 0.42%
- AUM
- 8.22B USD
- Expense ratio
- 0.18%
- Price / 1D
- $173.9+0.61%
Continue in GoAI
Research MIRresearch.disclaimer











